Acumen Pharmaceuticals, Inc. Common Stock
Symbol: ABOS (NASDAQ)
0.00
▼ (-100.00%) -1.390
Company Description:
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.39
- Yesterday High: $1.41
- Yesterday Low: $1.33
- Yesterday Volume: 122.28K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Acumen Pharmaceuticals, Inc. Common Stock
- Website: https://www.acumenpharm.com
- Listed Date: 2021-07-01
- Location: NEWTON, MA
- Market Status: Active
- CIK Number: 0001576885
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $81.77M
- Round Lot: 100
- Outstanding Shares: 60.57M
- Asset Type: CS
RECENT FILINGS FOR ABOS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-23 | ARS | View |
| 2025-04-23 | DEFA14A | View |
| 2025-04-23 | DEF 14A | View |
| 2025-03-31 | SCHEDULE 13D/A | View |
| 2025-03-27 | S-8 | View |
| 2025-03-27 | 10-K | View |
Latest News on ABOS